Allergy solutions for life
ALK (alk.net) earns a Brand Analyzer score of 75 out of 100, placing it in the Brand-Ready tier among Healthcare brands. Among 2305 Healthcare brands analyzed, ALK ranks in the 86th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 82/100, Visual Identity 94/100, Messaging Clarity 95/100, Trust Foundation 75/100, AI Discoverability 37/100, Brand Authority 53/100.
ALK is a Danish pharmaceutical company founded in 1923 and headquartered in Hørsholm, Denmark. Specializing in respiratory allergy research and treatment for over a century, ALK develops innovative allergy solutions aimed at addressing chronic conditions caused by immune overreactions. The company operates with a stated mission to reach 5 million people annually with allergy solutions by 2030, and emphasizes sustainable and ethical business practices.
| Brand Name | ALK |
|---|---|
| Domain | alk.net |
| Industry | Healthcare |
| Founded | 1923 |
| Headquarters | Hørsholm |
| Main Competitors | Stallergenes Greer, Allergy Therapeutics, HAL Allergy, Circassia, Aimmune Therapeutics |
Moz Domain Authority 53/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #471,106 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
ALK appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "ALK is on a mission to help more people globally with more allergy solutions more efficiently, reaching 5 million people a year by 2030." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
ALK scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ALK has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #471,106 (Tranco) and a Moz Domain Authority of 53/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ALK's main competitors include Stallergenes Greer, Allergy Therapeutics, HAL Allergy, Circassia, Aimmune Therapeutics. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: ALK official site
ALK is a Danish pharmaceutical company founded in 1923 and headquartered in Hørsholm, Denmark. It operates in the healthcare sector with a focus on respiratory allergy research and treatment. The company has been active in the allergy field for more than 100 years and positions itself at the forefront of allergy science, working to develop and deliver solutions for chronic allergic conditions caused by immune overreactions.
Sources: ALK official site
ALK researches, develops, and provides solutions for respiratory allergies and chronic allergic conditions. The company focuses on addressing the chronic disease caused by immune overreactions. Its mission is to help more people globally with more allergy solutions more efficiently, with a specific goal of reaching 5 million people per year by 2030. ALK also commits to sustainable and ethical operations across its business activities.
Sources: ALK official site
Popular alternatives to ALK include Stallergenes Greer, Allergy Therapeutics, HAL Allergy, Circassia, Aimmune Therapeutics. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: ALK official site
ALK has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 48, trust 19, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ALK official site
ALK was founded in 1923. ALK operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
ALK is headquartered in Hørsholm. ALK operates in the Healthcare category.
Sources: Wikidata
ALK and Stallergenes Greer are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: ALK official site
ALK is known for pioneering respiratory allergy research and treatment for over a century. The company has positioned itself as a long-standing leader in the allergy field, with more than 100 years of focus on understanding and treating chronic allergic conditions. It is recognized for its commitment to innovative allergy solutions and for its sustained dedication to sustainable and ethical business operations.
Sources: ALK official site
ALK scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: ALK official site
ALK's solutions are intended for people suffering from respiratory allergies and chronic allergic conditions worldwide. The company's mission targets a global audience, with a stated goal of reaching 5 million people per year by 2030. The target audience encompasses individuals affected by chronic conditions resulting from immune overreactions, suggesting ALK serves patients across a wide geographic and demographic range.
Sources: ALK official site
ALK can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ALK official site
ALK's prominence stems from its more than 100-year history as a specialist in respiratory allergy research and treatment, making it one of the longest-established companies in this niche area of healthcare. Its mission to reach 5 million people annually with allergy solutions by 2030 reflects a broad global reach. The company's focus on an underserved and widespread health issue - chronic respiratory allergies - contributes to its relevance among patients and healthcare providers.
Sources: ALK official site
Ranked closest to ALK: Alivia (75/100), Aline (75/100), AtmanCo (75/100), AvaHR (75/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).